Evidence map›Paper›PMID 28258222›Full record

ArticleThe Journal of biological chemistry2017

Molecular mechanism and structural basis of gain-of-function of STAT1 caused by pathogenic R274Q mutation.

Ryoji Fujiki, Atsushi Hijikata, Tsuyoshi Shirai, Satoshi Okada, Masao Kobayashi, Osamu Ohara

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ryoji FujikiFrom the Department of Technology Development, Kazusa DNA Research Institute, 2-6-7 Kazusa-Kamatari, Kisarazu-Shi, Chiba-Ken, 292-0818, fujiki@kazusa.or.jp.
Atsushi Hijikatathe Nagahama Institute of Bio-Science and Technology, 1266 Tamura, Nagahama-Shi, Shiga-Ken 526-0829, and.
Tsuyoshi Shiraithe Nagahama Institute of Bio-Science and Technology, 1266 Tamura, Nagahama-Shi, Shiga-Ken 526-0829, and.
Satoshi Okadathe Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-Ku, Hiroshima-Shi, Hiroshima-Ken 734-8551, Japan.
Masao Kobayashithe Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-Ku, Hiroshima-Shi, Hiroshima-Ken 734-8551, Japan.
Osamu OharaFrom the Department of Technology Development, Kazusa DNA Research Institute, 2-6-7 Kazusa-Kamatari, Kisarazu-Shi, Chiba-Ken, 292-0818.
Hiroshima University · JPKazusa DNA Research Institute · JPNagahama Institute of Bio-Science and Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gain-of-function (GOF) mutations in the

Indexed as

Candidiasis, Chronic MucocutaneousGene Expression RegulationMutation, MissenseSTAT1 Transcription FactorTranscription, GeneticAmino Acid SubstitutionHEK293 CellsHumansProtein DomainsProtein MultimerizationProtein Structure, SecondaryT-LymphocytesSTAT1 protein, humanSTAT1 Transcription FactorgeneticsJanus kinase (JAK)pathogenesissignal transducers and activators of transcription 1 (STAT1)transcription regulation

Identifiers

PMID28258222
PMCPMC5391754
OpenAlexW2592495929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.